Net profit of Concord Drugs declined 92.86% to Rs 0.04 crore in the quarter ended September 2024 as against Rs 0.56 crore during the previous quarter ended September 2023. Sales rose 64.36% to Rs 12.36 crore in the quarter ended September 2024 as against Rs 7.52 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.367.52 64 OPM %7.1221.41 - PBDT0.411.19 -66 PBT0.070.80 -91 NP0.040.56 -93 Powered by Capital Market - Live News

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2024.Powered by Capital Market - Live News

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September 2024.Powered by Capital Market - Live News